#cphftw #Cephagenix has raised €9M in seed funding from @AdBiopartners and @abbvie Ventures. The company is focused on developing selective vascular KATP channel inhibitors as a potential treatment for migraines. By @arcticstartup arcticstartup.com/cephagenix-r... #NordicMade #LifeScience
Danish joint venture secures €9 million in seed funding to advance anti-migraine research - ArcticStartup
Cephagenix, a Glostrup-based joint venture between Saniona and Professor Jes Olesen, has raised €9 million in seed funding from AdBio Partners and AbbVie
arcticstartup.com
January 29, 2025 at 4:30 PM
#cphftw #Cephagenix has raised €9M in seed funding from @AdBiopartners and @abbvie Ventures. The company is focused on developing selective vascular KATP channel inhibitors as a potential treatment for migraines. By @arcticstartup arcticstartup.com/cephagenix-r... #NordicMade #LifeScience